小儿肺炎患者的临床治疗体会  

Clinical Treatment Experience on Children Patients With Pneumonia

作　　者：迟瑛娇[1] 宋晓秋[1] 董秋华[1] 张泓[1] 邹艳红[2] 

机构地区：[1]哈尔滨市第一医院,150000 [2]佳木斯大学附属第一医院儿科,154003

出　　处：《中国卫生标准管理》2016年第3期36-37,共2页China Health Standard Management

摘　　要：目的探究小儿肺炎患者采用布地奈德雾化吸入治疗的方法和效果。方法选取2014年7月~2015年11月收治的131例小儿肺炎患者进行治疗,随机分组,实验组78例患者接受布地奈德雾化吸入治疗,对照组53例患者接受常规治疗,比较两组患者的治疗效果。结果对照组患者治疗的总有效率为83.02%,实验组患者治疗的总有效率为96.15%,经过对比发现,实验组患者的治疗效果高于对照组,且实验组患者各项症状消失的时间短于对照组,差异有统计学意义（P〈0.05）。结论小儿肺炎患者采用布地奈德雾化吸入治疗,可以提高治疗效果,减少不良反应,缩短住院时间。Objective Budesonide aerosol inhalation treatment method and its effect on children patients with pneumonia are to be studied. Methods Chose 131 children patients with pneumonia who were treated in hospital from July 2014 to November 2015 and separated them into two groups at random,78 patients in study group were given budesonide aerosol inhalation treatment,while 53 patients in control group were given conventional treatment,and then compared treatment effects between two groups. Results Patients＇ treatment efficacy in control group was 83.02% and patients＇ treatment efficacy in study group was 96.15%,thus,treatment efficacy in study group was much higher than that in control group,besides,it took less time for patients＇ symptoms to relieve in study group compared to that in control group,there was a treatment differential between two groups and such a differential had statistic value（P〈0.05）. Conclusion Budesonide aerosol inhalation treatment is quite effective on children patients with pneumonia,it is conducive to increasing treatment efficacy,reducing side-effect incidence and shortening patients＇ hospitalization days.

关 键 词：小儿肺炎患者 治疗效果 不良反应 

分 类 号：R563[医药卫生—呼吸系统]